mitomycin has been researched along with Ehlers-Danlos Syndrome in 1 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Ehlers-Danlos Syndrome: A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cordeiro, MF | 1 |
| Plant, GT | 1 |
| Child, A | 1 |
| Jones, B | 1 |
| Khaw, PT | 1 |
1 other study available for mitomycin and Ehlers-Danlos Syndrome
| Article | Year |
|---|---|
Visual loss after primary trabeculotomy with mitomycin C in Ehlers-Danlos syndrome.
Topics: Child; Ehlers-Danlos Syndrome; Female; Humans; Mitomycin; Nucleic Acid Synthesis Inhibitors; Trabecu | 1999 |